The urid ine-5-0-derivat ives, 5~methoxyuridine (mo5ll) and uridine-5-oxyacetic acid (cmo5U) occupy the first position of anticodons in certain tRNA species of B. subtilis and E. coli, respectively. Here we present experimental evidence showing that both modifications are derived from a common precursor, 5-hydroxyuridine. Incompletely modified tRNAAla, tRNAThr and tRNAVal were purified from B. subtilis, and submodified tRNASer and tRNAVal from E. coli met" rel". All five tRNAs accepted methyl groups from S-adenosylmethionine with B. subtilis extracts in vitro and mo5u was formed. In B. subtilis tRNAs the mo5u was proved to be at the specific site; in. E. ooli tRNAVal the mo5u was demonstrated to be present in the oligonucleotide that comprises the anticodon. In submethylated E. coli tRNAVal, 5~hydroxyuridine was detected whereas considerable amounts of cmo5(J were lacking.
INTRODUCTION

5-Methoxyuridine is analogous to uridine-5-oxyacetic acid (cmo U, formerly designated as V ) . This modification also occurs in the wobble position and
is present in tRNA Ser and tRNA Va1 of E. coli (6-8).
tRNA from E. ooli met rel (Kersten et a ) , unpublished). We have therefore suggested that in submethyiated E. ooli tRNA a precursor is present that is common for cnrcrU and mo 5 U and that t h i s precursor is 5-hydroxyuridine.
Here we present experimental evidence showing that specific submodified tRNAs from B. subtilis and E. coli are recognized by the B. subtilis tRNA-methyltransferase that forms mo U. The proposed precursor, 5-hydroxyur idine was detected in submethylated tRNA Val from E. ooli. plates (10x10 cm) were from Funacoshi Pharmaceutical Co., Tokyo; Polygram C-300 cellulose t h i n layer plates (20x20 cm) from Macherey-Nagel Co.
MATERIALS AND METHODS
Chemicals
Enzymes were from the following sources: RNAase T., Worthington Biochemical
Co; RNAase T 2> Calbiochem; Nuclease P., Yamasa Shoyu Co. Ltd. Tokyo;
Nuclease SW, Seikagaku Kogyo Co. Ltd. Tokyo.
For autoradiography Osray 1, film from Agfa-Gavaert, Belgium and for fluorography XR-5 X-ray f i l m from Kodak were used. Pactamycin was a kind g i f t from Upjohn Co., Mich. 5-Hydroxyuridine was synthesized by the method described by T. Ueda (10) .
Growth of bacteria:
E. coli K 12 58-161 met" spoT~ r e l " (Ikaken) was grown in 10 l i t r e of minimal medium with k mg of L-methionine per l i t r e (11). Cells were harvested at a late logarithmic phase. Pactamycin treated B. subtilis , W 23 was obtained as described previously ( 9 ) .
Crude tRNA and S-100 fractions:
Crude tRNA was prepared from pactamycin treated B. subtilis and from methionine starved E. coli (12) , S-100 f r a c t i o n s as sources of methylating enzymes from exponentially grown B. subtilis (13) .
Column and thin layer chromatography: Column chromatographies for the p u r i f i c a t i o n of tRNA were performed as described in the following references: DEAE-Sephadex A-50 ( H ) ; Sepharose ^B (15); BD-cellulose (16). Table 1 .
Preleminary experiments showed that bulk submethylated tRNA from E. coli also served as substrate for the B. subtilis enzyme that converts a precursor nucleoside to'no-'U.The extent of methylation of bulk submethylated tRNA from E. coli was found to be ten times higher as with the homo- as found to be only in the spot corresponding to mo Up (Fig. 5 ) .
The procedure of the whole sequence analysis is summarized in Fig. 6 for tRNA r as representative, in addition the proposed structures of the anticodons of tRNA a and tRNA r from B. subtilis are shown. E. coli tRNA (Fig. 8 ) . An extra minus charge derived from carboxyl ic acid of cmo U might make the complicated elution profile at the longest oligonucleotide region (Fig. 3 ) . An oligonucleotide was obtained from the region 10a that contained radioactive nKTU and m A. The radioactive products in peak 10b were almost all m A. 
